Inhibitory effect and its mechanism of 7-<i>O</i>-succinyl macrolactin A against cell proliferation, invasion and migration in human lung cancer H460 cells

YANG Peishu; HAO Wenli

doi:10.11665/j.issn.1000-5048.20170113

Journal of China Pharmaceutical University > 2017 > 48(1): 82-88. > DOI: 10.11665/j.issn.1000-5048.20170113

YANG Peishu, HAO Wenli. Inhibitory effect and its mechanism of 7-O-succinyl macrolactin A against cell proliferation, invasion and migration in human lung cancer H460 cells[J]. Journal of China Pharmaceutical University, 2017, 48(1): 82-88. DOI: 10.11665/j.issn.1000-5048.20170113

Citation:

PDF (2229 KB)

Inhibitory effect and its mechanism of 7-O-succinyl macrolactin A against cell proliferation, invasion and migration in human lung cancer H460 cells

YANG Peishu¹,
HAO Wenli²

More Information

Graphical Abstract

Abstract

Abstract

This study aimed at investigating the effects and mechanisms of 7-O-succinyl macrolactin A in inhibiting human lung cancer. After treatment of human lung cancer cell lines H460 with 7-O-succinyl macrolactin A, MTS assay was employed to determine cell proliferation; crystal violet staining was used to detect cell adhesion of H460; transwell chamber assay and wound healing assay were performed to evaluate cell invasion and migration; and flow cytometry assay was adopted to evaluate cell cycle. Western blotting and real-time PCR were also employed to determine the expression of β-catenin, c-Myc, Cyclin D1, vimentin, N-cadherin, CD44, integrin β1, Bcl-2, Survivin and MMP-2/9. The phosphorylation of AKT and mTOR was determined as well. In vitro proliferation of H460 was inhibited significantly by 7-O-succinyl macrolactin A. Cell adhesion, invasion and migration abilities were also attenuated. Western blot and real-time PCR showed that the expressions of β-catenin, c-Myc, cyclin D1, vimentin, N-cadherin, CD44, integrin β1, Bcl-2, Survivin and MMP-2/9 were down-regulated by 7-O-succinyl macrolactin A. It was also found that phosphorylation of AKT and mTOR was inhibited by 7-O-succinyl macrolactin A. 7-O-succinyl macrolactin A can inhibit the in vitro growth and invasion of human lung cancer cell lines H460.
- 7-O-succinyl macrolactin A,
- lung cancer,
- H460,
- anti-tumor,
- anti-invasion

FullText(HTML)

References (20)

References

[1]	Gao Y,Zhao Y,Yao J,et al.Wogonin suppresses human alveolar adenocarcinoma cell A549 invasion and metastasis induced by IL-6[J].J China Pharm Univ(中国药科大学学报),2015,46(3):345-349.
[2]	Santos AA,Matos AJ.Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours.Part 2:invasion,angiogenesis,metastasis and therapy[J].Vet J,2015,205(2):144-153.
[3]	Romero-Tabarez M,Jansen R,Sylla M,et al.7-O-malonyl macrolactin A,a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus,Vancomycin-resistant enterococci,and a small-colony variant of Burkholderia cepacia[J].Antimicrob Agents Chemother,2006,50(5):1701-1709.
[4]	Kim DH,Kim HK,Kim KM,et al.Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus[J].Arch Pharm Res,2011,34(1):147-152.
[5]	Wu X,Zhu Y,Yan H,et al.Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells[J].BMC Cancer,2010,9(10):269.
[6]	Reck M,Popat S,Reinmuth N,et al.Metastatic non-small-cell lung cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2014,25(Suppl 3):iii27-39.
[7]	Spano D,Heck C,De Antonellis P,et al.Molecular networks that regulate cancer metastasis[J].Semin Cancer Biol,2012,22(3):234-249.
[8]	Han B,Guo Z,Ma Y,et al.Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy[J].Int J Clin Exp Pathol,2015,8(4):4113-4119.
[9]	Al-Taweel AM,Perveen S,Fawzy GA,et al.Cytotoxicity assessment of six different extracts of abelia triflora leaves on A549 human lung adenocarcinoma cells[J].Asian Pac J Cancer Prev,2015,16(11):4641-4645.
[10]	Regmi SC,Park SY,Kim SJ,et al.The anti-tumor activity of succinyl macrolactin A is mediated through the β-catenin destruction complex via the suppression of tankyrase and PI3K/Akt[J].PLoS One,2015,10(11):e0141753.
[11]	Kang Y,Regmi SC,Kim MY,et al.Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling[J].Arch Pharm Res,2015,38(2):249-260.
[12]	Zhao R,Chen M,Jiang Z,et al.Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways[J].J Cancer,2015,6(7):623-631.
[13]	Gu CP,Que FC,Li YL,et al.Cisplatin inhibits survival of human esophageal squamous carcinoma cells via p53 activation[J].J China Pharm Univ(中国药科大学学报),2016,47(1):90-94.
[14]	Liu W, Ren H, Ren J, et al. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma[J].Mediators Inflamm,2013:651207.
[15]	Ku JH,Seo SY,Kwak C,et al.The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells[J].Urol Oncol,2012,30(5):562-568.
[16]	Shay G,Lynch CC,Fingleton B.Moving targets:emerging roles for MMPs in cancer progression and metastasis[J].Matrix Biol,2015,44-46:200-206.
[17]	Wang R,Ke ZF,Wang F,et al.GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9[J].Cell Physiol Biochem,2015,35(3):969-982.
[18]	Zhang H,Guo M,Chen JH,et al.Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway[J].Cell Physiol Biochem,2014,33(4):991-1002.
[19]	Park S,Regmi SC,Park SY,et al.Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways[J].Eur J Pharmacol,2014,735:184-192.
[20]	Ponnusamy MP,Seshacharyulu P,Lakshmanan I,et al.Emerging role of mucins in epithelial to mesenchymal transition[J].Curr Cancer Drug Targets,2013,13(9):945-956.

[1]	CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
[2]	FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
[3]	TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405
[4]	SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
[5]	CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103
[6]	SUN Jingfang, GUO Chunjing, ZHANG Yunduan, SONG Xiaoyan, LYU Jiantao, YIN Jungang, CHEN Daquan. Preparation and characterization of multi-functional targeting nano-carrier based on pH-redox tumor microenvironment[J]. Journal of China Pharmaceutical University, 2017, 48(3): 305-310. DOI: 10.11665/j.issn.1000-5048.20170309
[7]	SHANG Yunkai, JU Caoyun, XIE Daping, ZHANG Can. Preparation and characterization of tumor targeting doxorubicin liposomesmodified via click chemistry[J]. Journal of China Pharmaceutical University, 2016, 47(6): 708-713. DOI: 10.11665/j.issn.1000-5048.20160613
[8]	XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602
[9]	SHI Yongping, SU Zhigui, XIAO Yanyu, SUN Minjie, PING Qineng, ZONG Li. Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor[J]. Journal of China Pharmaceutical University, 2013, 44(4): 321-327. DOI: 10.11665/j.issn.1000-5048.20130407
[10]	Tumor microenvironment：A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10.

Cited By

Get Citation

PDF

XML

Article views (797) PDF downloads (1561)

Turn off MathJax

Article Contents

Abstract

References

Inhibitory effect and its mechanism of 7-O-succinyl macrolactin A against cell proliferation, invasion and migration in human lung cancer H460 cells

Abstract

References

Related Articles

Catalog

Inhibitory effect and its mechanism of 7-O-succinyl macrolactin A against cell proliferation, invasion and migration in human lung cancer H460 cells

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content